The Journey in Fighting the COVID-19 Pandemic: What can patients expect?

This session was a follow-through from our Global Patients Congress 2020 where we had IFPMA and its members shared updates on the COVID-19 vaccine research and development. This session came at the half-way mark in the research and development of the COVID-19 vaccine.
Speakers discussed the progress in discovering treatment options for COVID-19 patients, which was critical at this point as we eagerly awaited for the vaccines to be available. The session also asked the question: where is Asia Pacific in all the R&D efforts and its future plans to ensure affordable and equitable access for all.